251 related articles for article (PubMed ID: 17900981)
1. Homocysteine in restless legs syndrome.
Bachmann CG; Guth N; Helmschmied K; Armstrong VW; Paulus W; Happe S
Sleep Med; 2008 May; 9(4):388-92. PubMed ID: 17900981
[TBL] [Abstract][Full Text] [Related]
2. Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients.
Valkovic P; Benetin J; Blazícek P; Valkovicová L; Gmitterová K; Kukumberg P
Parkinsonism Relat Disord; 2005 Jun; 11(4):253-6. PubMed ID: 15878587
[TBL] [Abstract][Full Text] [Related]
3. Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease.
O'Suilleabhain PE; Bottiglieri T; Dewey RB; Sharma S; Diaz-Arrastia R
Mov Disord; 2004 Dec; 19(12):1403-8. PubMed ID: 15390053
[TBL] [Abstract][Full Text] [Related]
4. Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients.
Lamberti P; Zoccolella S; Iliceto G; Armenise E; Fraddosio A; de Mari M; Livrea P
Mov Disord; 2005 Jan; 20(1):69-72. PubMed ID: 15390046
[TBL] [Abstract][Full Text] [Related]
5. Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study.
Postuma RB; Espay AJ; Zadikoff C; Suchowersky O; Martin WR; Lafontaine AL; Ranawaya R; Camicioli R; Lang AE
Neurology; 2006 Jun; 66(12):1941-3. PubMed ID: 16801668
[TBL] [Abstract][Full Text] [Related]
6. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
7. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations.
Ozer F; Meral H; Hanoglu L; Aydemir T; Yilsen M; Cetin S; Ozturk O; Seval H; Koldas M
Neurol Res; 2006 Dec; 28(8):853-8. PubMed ID: 17288745
[TBL] [Abstract][Full Text] [Related]
9. No association between neuropathy and restless legs in Parkinson's disease.
Rajabally YA; Martey J
Acta Neurol Scand; 2013 Mar; 127(3):216-20. PubMed ID: 22989006
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study.
Anamnart C; Kitjarak R
J Clin Neurosci; 2021 Jun; 88():226-231. PubMed ID: 33992189
[TBL] [Abstract][Full Text] [Related]
11. [Effects of entacapone on plasma homocysteine in Parkinson's disease patients on levodopa].
Zhao P; Yang JF; Liu W; Wang Y; Sun YN; Li Q; Zhang W; Zhang BS
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):512-5. PubMed ID: 23660319
[TBL] [Abstract][Full Text] [Related]
12. The influence of levodopa and the COMT inhibitor on serum vitamin B12 and folate levels in Parkinson's disease patients.
Triantafyllou NI; Kararizou E; Angelopoulos E; Tsounis S; Boufidou F; Evangelopoulos ME; Nikolaou C; Vassilopoulos D
Eur Neurol; 2007; 58(2):96-9. PubMed ID: 17565222
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
[TBL] [Abstract][Full Text] [Related]
14. Association of B vitamins status and homocysteine levels in elderly Taiwanese.
Chen KJ; Pan WH; Yang FL; Wei IL; Shaw NS; Lin BF
Asia Pac J Clin Nutr; 2005; 14(3):250-5. PubMed ID: 16169836
[TBL] [Abstract][Full Text] [Related]
15. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction.
Iqbal MP; Ishaq M; Kazmi KA; Yousuf FA; Mehboobali N; Ali SA; Khan AH; Waqar MA
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):100-8. PubMed ID: 15871858
[TBL] [Abstract][Full Text] [Related]
16. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
17. The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status.
Zesiewicz TA; Wecker L; Sullivan KL; Merlin LR; Hauser RA
Clin Neuropharmacol; 2006; 29(3):106-11. PubMed ID: 16772808
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
Camicioli RM; Bouchard TP; Somerville MJ
Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease.
Fimognari FL; Loffredo L; Di Simone S; Sampietro F; Pastorelli R; Monaldo M; Violi F; D'Angelo A
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):654-9. PubMed ID: 19282159
[TBL] [Abstract][Full Text] [Related]
20. [Homocysteine related vitamins and lifestyles in the elderly people: The SENECA study].
Varela-Moreiras G; Escudero JM; Alonso-Aperte E
Nutr Hosp; 2007; 22(3):363-70. PubMed ID: 17612379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
